Product Information

ROPINIROLE HCL ER 2 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.4286 per EA under NDC 55111065990. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jun 6, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ROPINIROLE HCL ER 2 MG TABLET

Ropinirole
$0.4286per EA

Strength

2 mg/1

NDC

55111065990

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ROPINIROLE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA201576

FDA Approved

6/6/2012

TE Code

AB

On Market Since

6/6/2012

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for ROPINIROLE HCL ER 2 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4286 per EA
All-time high$2.0158 (Feb 12, 2014)
All-time low$0.3487 (Sep 23, 2026)
52-week high$0.4370
52-week low$0.3487
Median price$0.7745
Average price$0.8654
Largest weekly change+51.2% (Apr 18, 2018)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+3.5%

1M

+22.9%

3M

+13.2%

6M

-1.9%

1Y

+10.2%

3Y

-22.2%

5Y

-43.8%

All

-75.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ROPINIROLE HCL ER 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 2 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.4286 per EA (NDC 55111065990), effective Nov 18, 2026.

How has the price of ROPINIROLE HCL ER 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for ROPINIROLE HCL ER 2 MG TABLET has declined 75.6%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 2 MG TABLET?

Since Nov 28, 2013, the NADAC for ROPINIROLE HCL ER 2 MG TABLET has ranged from a low of $0.3487 (Sep 23, 2026) to a high of $2.0158 (Feb 12, 2014), with a median of $0.7745 per EA.

Are there cheaper alternatives to ROPINIROLE HCL ER 2 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROPINIROLE HCL 2 MG TABLET, is $0.0622 per EA — about 85% below ROPINIROLE HCL ER 2 MG TABLET.

Who manufactures ROPINIROLE HCL ER 2 MG TABLET?

ROPINIROLE HCL ER 2 MG TABLET (NDC 55111065990) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.